A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor Receptor 2 Levels and Risk of Ovarian Cancer

作者：Poole Elizabeth M^*; Lee I Min; Ridker Paul M; Buring Julie E; Hankinson Susan E; Tworoger Shelley S

来源：American Journal of Epidemiology, 2013, 178(8): 1256-1264.

DOI：10.1093/aje/kwt098

• C-reactive protein
• interleukin 6
• ovarian cancer
• tumor necrosis factor receptor 2

Chronic inflammation may play a role in ovarian carcinogenesis. We examined associations between 3 plasma biomarkers of inflammationuC-reactive protein (CRP), interleukin 6, and tumor necrosis factor receptor 2uand risk of invasive epithelial ovarian cancer in prospectively collected samples from the Nurses Health Study (NHS; 19892010), Nurses Health Study II (NHS II; 19962009), and the Womens Health Study (WHS; 19922011) and performed a meta-analysis including data from previous publications. Associations with ovarian cancer risk were calculated using logistic regression (NHS/NHS II; n 217 cases) or Cox proportional hazards regression (WHS; n 159 cases). Study-specific results were combined using random-effects meta-analysis. In the NHS/NHS II and WHS, we observed a 53 increased risk of invasive ovarian cancer when comparing women in the fourth quartile of CRP with women in the first quartile (95 confidence interval (CI): 1.05, 2.23). A CRP level of 10 mg/L versus a level of 1 mg/L was associated with a 2.16-fold increased risk (95 CI: 1.23, 3.78). In a meta-analysis of published studies, women in the third tertile of CRP had a 35 increased risk (95 CI: 1.10, 1.67) compared with women in the first tertile. There were no significant associations between interleukin 6 or tumor necrosis factor receptor 2 and risk in the NHS/NHS II. Our results support the hypothesis that higher levels of circulating CRP are associated with increased risk of ovarian cancer, indicating that the role of inflammation in ovarian cancer requires further elucidation.

• 出版日期2013-10-15